vision issues with tirzepatide GLP-1s and Eye Health: What You Need to Know Vision loss risks in patients
Description
As the first and only dual-activating GIP and GLP-1 obesity treatment, ZEPBOUND, Eli Lilly weight loss medication, addresses a key factor contributing to excess weight by curbing appetite and reducing food intake
Increasing heart rate Worsening depression, behavior changes, or suicidality SIDE EFFECTS Many people experience no side effects
You are setting yourself up for muscle loss, nutrient deficiencies, fatigue, hair loss , and eventual weight regain
This precision matters when titrating through the escalation protocol to find your optimal maintenance dose
